Evidence map›Paper›PMID 31953794›Full record

ReviewBiophysical reviews2020

Microfluidic technologies to engineer mesenchymal stem cell aggregates-applications and benefits.

Seyedeh Sarah Salehi, Amir Shamloo, Siamak Kazemzadeh Hannani

Abstract readReview
In one paragraph

Review in Biophysical reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Immunomodulatory Delivery Materials for Tissue Repair.Advanced healthcare materials · 2025
    Review
  2. Article
  3. Rewiring the Spine-Cutting-Edge Stem Cell Therapies for Spinal Cord Repair.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Seyedeh Sarah SalehiSchool of Mechanical Engineering, Sharif University of Technology, Tehran, Iran.
Amir ShamlooSchool of Mechanical Engineering, Sharif University of Technology, Tehran, Iran. shamloo@sharif.edu.ORCID http://orcid.org/0000-0002-0131-0567
Siamak Kazemzadeh HannaniSchool of Mechanical Engineering, Sharif University of Technology, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional cell culture and the forming multicellular aggregates are superior over traditional monolayer approaches due to better mimicking of in vivo conditions and hence functions of a tissue. A considerable amount of attention has been devoted to devising efficient methods for the rapid formation of uniform-sized multicellular aggregates. Microfluidic technology describes a platform of techniques comprising microchannels to manipulate the small number of reagents with unique properties and capabilities suitable for biological studies. The focus of this review is to highlight recent studies of using microfluidics, especially droplet-based types for the formation, culture, and harvesting of mesenchymal stem cell aggregates and their subsequent application in stem cell biology, tissue engineering, and drug screening. Droplet-based microfluidics can be used to form microgels as carriers for delivering cells and to provide biological cues to the target tissue so as to be minimally invasive. Stem cell-laden microgels with a shape-forming property can be used as smart building blocks by injecting them into the injured tissue thereby constituting the cornerstone of tissue regeneration.

Indexed as

BioinkDropletMesenchymal stem cellsMicrofluidicsMulticellular aggregates

Identifiers

PMID31953794
PMCPMC7040154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.